secwatch.observer — SEC 8-K summary
======================================

Issuer:     Grace Therapeutics, Inc. (GRCE)
CIK:        0001444192
Form:       8-K
Filed at:   2023-07-07T23:59:59+00:00
Accession:  0000950170-23-032154
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acasti Pharma announces 1-for-6 reverse stock split to regain Nasdaq minimum bid price compliance
--------------------------------------------------------------------------------

- Reverse split at 1-for-6 effective July 10, 2023; shares trade on split-adjusted basis from market open.
- Outstanding shares reduced from ~44.6M to ~7.4M; no fractional shares issued, rounded up to whole share.
- Split intended to regain compliance with Nasdaq $1.00 minimum bid price continued listing requirement.
- New CUSIP number is 00430K865; trading symbol remains ACST.
- Transfer agent Computershare will handle exchanges; street-name holders need not take action.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444192/000095017023032154/0000950170-23-032154-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444192/000095017023032154/acst-20230704.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-032154

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer